topoisomerase-IV inhibitor (Daiichi Sankyo Life Science Research Center in India)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nametopoisomerase-IV inhibitor (Daiichi Sankyo Life Science Research Center in India)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionTopoisomerase IV inhibitors
TargetsTopoisomerase IV
Therapy Area/IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Life Science Research Center in India
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Life Science Research Center in India
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A